EDN1 and prostate carcinoma: Endothelin-1 (ET-1) is a major representative, consistently implicated in prostate cancer (PC) progression through induction of proliferation of PC cells in vitro, while in vivo, increased ET-1 levels were detected in plasma and tissue specimens from patients with castrate-resistant PC [1–3].